LENZ Therapeutics, Inc. SEC filings LENZ
LENZ Therapeutics, Inc. has 359 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations, exit or restructuring costs, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 24, 2026 | — |
| 424B5 | Prospectus supplement | Apr 14, 2025 | — |
| 424B3 | Prospectus | Apr 14, 2025 | — |
| 424B3 | Prospectus | Apr 9, 2025 | — |
| 424B3 | Prospectus | Apr 9, 2025 | — |
| S-3 | Shelf registration | Apr 4, 2025 | — |
| S-3 | Shelf registration | Apr 4, 2025 | — |
| POS AM | Filing | Apr 4, 2025 | — |
| POS AM | Filing | Apr 4, 2025 | — |
| S-8 | Employee stock plan registration | Mar 19, 2025 | — |
| 424B3 | Prospectus | Nov 6, 2024 | — |
| 424B3 | Prospectus | Nov 6, 2024 | — |
| 424B3 | Prospectus | Oct 28, 2024 | — |
| 424B3 | Prospectus | Oct 28, 2024 | — |
| 424B3 | Prospectus | Sep 19, 2024 | — |
| S-1 | Registration statement | Sep 11, 2024 | — |
| 424B3 | Prospectus | Aug 14, 2024 | — |
| 424B3 | Prospectus | Aug 12, 2024 | — |
| 424B3 | Prospectus | Jul 15, 2024 | — |
| S-8 | Employee stock plan registration | May 21, 2024 | — |
| 424B3 | Prospectus | May 9, 2024 | — |
| 424B3 | Prospectus | Apr 11, 2024 | — |
| S-1/A | Amended registration statement | Apr 9, 2024 | — |
| S-1 | Registration statement | Mar 29, 2024 | — |
| 424B3 | Prospectus | Feb 13, 2024 | — |
| S-4/A | Filing | Feb 9, 2024 | — |
| S-4/A | Filing | Feb 5, 2024 | — |
| S-4/A | Filing | Jan 18, 2024 | — |
| S-4 | Registration for a merger or exchange | Dec 6, 2023 | — |
| S-8 | Employee stock plan registration | Mar 20, 2023 | — |
| S-3 | Shelf registration | Jul 21, 2022 | — |
| S-8 | Employee stock plan registration | Mar 21, 2022 | — |
| S-8 | Employee stock plan registration | Jun 28, 2021 | — |
| 424B4 | Prospectus | Jun 28, 2021 | — |
| S-1MEF | Filing | Jun 24, 2021 | — |
| S-1/A | Amended registration statement | Jun 22, 2021 | — |
| S-1/A | Amended registration statement | Jun 21, 2021 | — |
| S-1/A | Amended registration statement | Jun 11, 2021 | — |
| S-1 | Registration statement | Jun 4, 2021 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- LENZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1815776
- Former names
- Graphite Bio, Inc. (until Mar 19, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.